To gain a deeper understanding of the transcriptomic remolding in those neutrophils and whether such remolding depends on c-Met signaling in tumor cells, we performed RNA sequencing in mouse neutrophils treated with CM of 231BrM-tet-shMet cells with or without knockdown of c-Met. The gene discussed is MET; the disease is neoplasm.